BindingDB

The first public molecular recognition database, BindingDB supports research, education and practice in drug discovery, pharmacology and related fields.

BindingDB contains 3.2M data for 1.4M Compounds and 11.4K Targets. Of those, 1.6M data for 745K Compounds and 4.7K Targets were curated by BindingDB curators. BindingDB is a FAIRsharing resource.

If BindingDB was of value to your research, please take a moment to donate to this nonprofit project. Your donation will let us provide you with more data and improved service.

Donate Now

To help with training and testing AI and other models, BindingDB downloads and search results now provide the publication date and BindingDB curation date of each measurement.

Advanced Search

26 articles for H Kondo

The following articles (labelled with PubMed ID or TBD) are for your review

PMID
Data
Article Title
Organization
Synthesis and antibacterial activity of new tetracyclic quinolone antibacterials.EBI
Kanebo
New type of metalloproteinase inhibitor: design and synthesis of new phosphonamide-based hydroxamic acids.EBI
Nippon Organon K.K.
Study on selectin blocker. 8. Lead discovery of a non-sugar antagonist using a 3D-pharmacophore model.EBI
Nippon Organon K.K.
Studies on selectin blockers. 7. Structure-activity relationships of sialyl Lewis X mimetics based on modified Ser-Glu dipeptides.EBI
Kanebo
Studies on selectin blockers. 6. Discovery of homologous fucose sugar unit necessary for E-selectin binding.EBI
Kanebo
Studies on selection blockers. 5. Design, synthesis, and biological profile of sialyl Lewis x mimetics based on modified serine-glutamic acid dipeptides.EBI
Kanebo
Studies on selectin blocker. 1. Structure-activity relationships of sialyl Lewis X analogs.EBI
Institute of Cancer Research
Studies on selectin blocker. 3. Investigation of the carbohydrate ligand sialyl Lewis X recognition site of P-selectin.EBI
Kanebo
Studies on selectin blockers. 2. Novel selectin blocker as potential therapeutics for inflammatory disorders.EBI
New Drug Research Laboratory
A solid-phase synthesis for beta-turn mimetics of sialyl Lewis X.EBI
Nippon Organon K.K.
An efficient approach to the discovery of potent inhibitors against glycosyltransferases.EBI
Hokkaido University
 
Design and synthesis of an α-mannosyl terpenoid as selective inhibitor of P-selectinEBI
TBA
Azasugar-based MMP/ADAM inhibitors as antipsoriatic agents.EBI
Hokkaido Collaboration Center N-21
Synthesis and biological activity of selective azasugar-based TACE inhibitors.EBI
Organon K.K.
Design, synthesis and evaluation of novel azasugar-based MMP/ADAM inhibitors.EBI
Hokkaido Collaboration Center
Structure--activity relationships of azasugar-based MMP/ADAM inhibitors.EBI
Hokkaido Collaboration Center
Discovery of selective phosphonamide-based inhibitors of tumor necrosis factor-alpha converting enzyme (TACE).EBI
Organon K.K.
Encounter with unexpected collagenase-1 selective inhibitor: switchover of inhibitor binding pocket induced by fluorine atom.EBI
Organon K.K.
New strategy for antedrug application: development of metalloproteinase inhibitors as antipsoriatic drugs.EBI
Organon K.K.
Design and synthesis of dual inhibitors for matrix metalloproteinase and cathepsin.EBI
Organon K.K.
Drug design, synthesis, and evaluation of a non-sugar-based selectin antagonist.EBI
Organon K.K.
Synthesis and biological activities of topoisomerase I inhibitors, 6-N-amino analogues of NB-506.EBI
Banyu Tsukuba Research Institute
Selectin-ligand interactions revealed by molecular dynamics simulation in solution.EBI
Kanebo
Pharmaceutical combination comprising an ALK inhibitor and a SHP2 inhibitorBDB
Novartis
Synthesis and carbonic anhydrase isoenzymes I and II inhibitory effects of novel benzylamine derivatives.BDB
Ataturk University
Triazolopyridine compoundsBDB
Hoffmann-La Roche